Open AccessP568: REAL‐LIFE EXPERIENCE OF TREATMENT REFRACTORY/RELAPSED ACUTE MYELOID LEUKEMIA PATIENTS WITH VENETOCLAX COMBINATION THERAPY
Author(s) -
Pomares Marin H.,
Villarreal Hernández J.,
Condom Esteve M.,
Vives Polo S.,
Cervera Calvo M.,
Coll Jorda R.,
Maluquer Artigal C.,
Ibarra Fernández G.,
Torrent Catarineu A.,
Galiano Barajas M.,
Sureda Balari A. M.,
Arnan Sangerman M.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845160.95755.c5
Subject(s) - venetoclax , azacitidine , decitabine , medicine , cytarabine , hypomethylating agent , myeloid leukemia , oncology , refractory (planetary science) , leukemia , chronic lymphocytic leukemia , astrobiology , biochemistry , gene expression , chemistry , physics , dna methylation , gene